Sotatercept: from clinical trials to real world data & pearls from practice

Presented at PVRI 2026 Congress by Ioana Preston, Lahey Hospital & Medical Center

Summary

Explore the development and clinical trials of a new drug for PAH. Historical treatment methods and genetic discoveries are highlighted. Pivotal trials show improved patient outcomes, including lower mortality rates and better exercise capacity. Safety profiles are discussed, focusing on adverse events and the need for long-term monitoring. The community is urged to continue research and dialogue on treatment strategies.

Generated with AI, edited by PVRI